Skip to main content
Equibles

Man Group plc

Position in CGON — CG Oncology, Inc.

CIK 1637460 LONDON, X0
Back to CGON Full portfolio

Position in CGON

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,683,871
+$3,459,777 QoQ
Shares Held
51,849
+501.6% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. CGON ranks #45 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5
397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in CGON

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,683,871 51,849
2025-06-30 $224,094 8,619